Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
1.100
-0.080 (-6.78%)
At close: Dec 5, 2025, 4:00 PM EST
1.090
-0.010 (-0.91%)
After-hours: Dec 5, 2025, 7:47 PM EST
Mangoceuticals Revenue
Mangoceuticals had revenue of $84.25K in the quarter ending September 30, 2025, a decrease of -36.83%. This brings the company's revenue in the last twelve months to $466.91K, down -38.16% year-over-year. In the year 2024, Mangoceuticals had annual revenue of $615.87K, down -15.81%.
Revenue (ttm)
$466.91K
Revenue Growth
-38.16%
P/S Ratio
16.91
Revenue / Employee
$155,636
Employees
3
Market Cap
15.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 615.87K | -115.62K | -15.81% |
| Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
| Dec 31, 2022 | 8.94K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGRX News
- 22 days ago - Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs - GlobeNewsWire
- 22 days ago - Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs - Reuters
- 23 days ago - Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs - Reuters
- 6 months ago - Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu - GlobeNewsWire
- 7 months ago - ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - Newsfile Corp
- 8 months ago - CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 8 months ago - ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 8 months ago - Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - GlobeNewsWire